Podcasts about Genetic testing

Vasanta Pundarika built her career inside healthcare investment banking before launching Lotuspring, an advisory firm focused on women's health and behavioral health. She spent nearly 20 years advising healthcare systems, treatment providers, and growth stage companies on mergers, financing, and operational strategy while watching the industry repeatedly misunderstand the people it claimed to serve.The conversation starts unexpectedly with anthropology, bread, and language. Vasanta explains how she spent years changing the pronunciation of her own name to make other people comfortable before eventually reclaiming it. That thread opens into a much larger discussion about adaptation, identity, and what institutions quietly train people to tolerate.From there, the discussion moves into behavioral health, women delaying care, and the invisible labor that healthcare business models routinely ignore. During COVID, Vasanta noticed men's behavioral health units refilled faster than women's units. The reason had nothing to do with demand. Women were still home managing caregiving responsibilities, children, aging parents, and households while their own mental health collapsed in the background.The episode examines what happens when healthcare companies become “snazzy big brands” before building real clinical substance underneath. Vasanta describes the tension between mission and margin inside healthcare startups, private equity backed care models, and behavioral health expansion. The conversation pushes on who benefits when healthcare scales aggressively, who absorbs the operational pressure, and how patient trust erodes long before executives notice it on a dashboard.They also discuss patient advocacy culture, anthropology as systems analysis, healthcare capitalism, prior authorization, investor language, and why some clinically excellent companies never survive long enough to scale.RELATED LINKSVasanta PundarikaLotuspringWomen's Health HorizonsSakhi for South Asian SurvivorsNACDPrinceton University Anthropology DepartmentFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Are you exploring intrauterine insemination (IUI) to grow your family? In this episode of Fertility Docs Uncensored, hosts Dr. Carrie Bedient from The Fertility Center of Las Vegas and Dr. Susan Hudson from the Texas Fertility Center discuss key patient questions about intrauterine insemination cycles and the newer intratubal insemination cycles. In this comprehensive episode, we break down exactly how an IUI cycle works, who benefits the most, and the strict medical guidelines required for success. We dive deep into the absolute necessity of accurate cycle timing, explaining how a luteinizing hormone (LH) surge or a hCG trigger shot dictates the precise 24-to-36-hour insemination window. You will also learn the critical differences between preconception screening and IVF testing—specifically, what genetic testing can and cannot do during an IUI cycle. Finally, we look at the raw numbers. We discuss mandatory medical requirements, minimal post-wash sperm counts, and realistic IUI success rates by age to help you manage expectations on your fertility journey.

Artificial Intelligence is buzzy. There's a lot about it in the news and a lot we think we understand about how to use it and a lot we may not fully understand. But the promise it holds is tremendous, and today we're going to learn a little more about how it could benefit breast cancer research and patient care in the near future. Drs. Charles Perou at UNC Chapel Hill and Erika Crosby at Duke University are two very accomplished breast cancer researchers who are joining us today to share their perspectives on using AI now and in the future. Key takeaways AI is improving breast cancer screening and diagnosis. Researchers are using AI to save time on coding, writing, and data analysis. AI can help match patients to clinical trials more effectively. Human expertise is still needed to verify AI-generated results. AI has the potential to accelerate research and improve patient care. Chapters 00:00 — Introduction to AI in Breast Cancer Research 02:53 — Ethical Considerations and Responsible AI Use 04:33 — Current Clinical Applications of AI 08:12 — How Researchers Are Using AI in the Lab 11:17 — AI Limitations, Mistakes, and Critical Thinking 17:23 — The Future of AI-Assisted Cancer Research Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

It’s estimated that millions of Americans have learned through home genetic tests that they’re not actually biologically related to a parent. Most aren’t prepared for this surprise. And many aren’t briefed with informed consent before getting the news. Betty Cohn has a Ph.D. in Public Health Genetics from the University of Washington. For her dissertation, she spoke with people who had this experience. To learn more before doing genetic testing, check out this Genetic Testing Consent Informational Flyer We can only make Seattle Now because listeners support us. Tap here to make a gift and keep Seattle Now in your feed. Got questions about local news or story ideas to share? We want to hear from you! Email us at seattlenow@kuow.org, leave us a voicemail at (206) 616-6746 or leave us feedback online or on the KUOW App.See omnystudio.com/listener for privacy information.

Brad Power spent years advising major corporations on systems design, process engineering, and decision making before lymphoma shoved him into the patient side of American healthcare. Instead of accepting the experience at face value, he started reverse engineering the machinery around cancer itself. Brad is the founder of Cancer Patient Lab and Open Cancer AI, two projects built around a blunt reality most patients discover too late: the healthcare system rewards people who know how to navigate it. Everyone else risks getting steamrolled by information asymmetry, insurance barriers, administrative friction, and institutional incentives designed around efficiency instead of human survival.The conversation starts with Harvard Business Review and Tumblr blogs before moving directly into the darker architecture underneath modern cancer care. Power explains how hospitals optimize for throughput, how insurance companies reward operational consistency over personalized medicine, and why many patients quietly end up needing a crash course in oncology, reimbursement policy, and behavioral psychology while fighting for their lives.The discussion digs into CAR-T therapy, functional testing, AI assisted decision support, and the growing collision between personalized medicine and standardized care pathways. Power argues that engaged patients often get better outcomes because they learn how to push for off guideline treatments, contest denials, and ask smarter questions. The counterpoint lands hard: patients should never have needed to become experts in the first place.The episode also explores the cultural consequences of AI entering cancer care. OpenAI advertising, data privacy, trust erosion, pharmaceutical influence, and “agentic AI” all collide inside a healthcare economy already drowning in distrust. Power sees artificial intelligence as a force multiplier for patient literacy and access. The larger system still decides who gets approved, who gets delayed, and who gets left behind.By the end, the conversation lands exactly where modern healthcare keeps forcing people to land: survival increasingly depends on learning how the machine works before the machine works on you.RELATED LINKSBrad PowerCancer Patient LabOpen Cancer AIHarvard Business ReviewResearch to the PeopleCAR T Cell TherapyFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

We know that clinical trials are a critical lifeline, offering new ways to prevent, detect, diagnose and treat breast cancer. Today, patient advocates are transforming clinical trials by bringing the real-world experiences of patients directly to researchers. By acting as a bridge between science and the community, patient advocates boost enrollment in clinical trials, and help build a lasting trust Today we are speaking with Dr. Lior Braunstein, a radiation oncologist and researcher at Memorial Sloan Kettering Cancer Center, and Dr. Ellen Landsberger, a retired OB-GYN and patient advocate, also at Memorial Sloan Kettering Cancer Center. Together they are working on the ARCHER clinical trial, a study that is investigating a new treatment strategy for HER2-positive metastatic breast cancer. We'll talk about what they are hoping to accomplish through the ARCHER trial, what their collaborative process looks like and how patient advocates in clinical trials can help improve patient outcomes. Key Takeaways: Patient advocates help design better clinical trials The ARCHER trial aims to improve treatment outcomes Patient voices shape research from the very beginning Clinical trials study both treatment and quality of life Better access helps more patients join clinical trials Chapters 00:00:00 – Why patient advocates belong at the clinical trial design table 00:04:44 – From breast cancer survivor to patient advocate 00:07:46 – How advocates shape research and address patient concerns 00:12:08 – Inside the ARCHER trial and its goal to improve metastatic breast cancer treatment 00:19:03 – Measuring quality of life and improving access to clinical trials 00:26:28 – How patients can become advocates and influence future research

Integrative oncologist Dr. Nina Fuller-Shavel joins me to explain why cancer rates are climbing in midlife women, even those who look healthy on paper. WHAT YOU'LL LEARN -       Why cancer rates are rising even in midlife women who look and feel healthy -       The gut-estrogen connection: how your microbiome affects hormone-driven cancer risk -       The 3 simple interventions that cut cancer risk by 60% in a landmark trial -       How strength training lowers inflammation and disease risk -       Why lifetime estrogen exposure matters more than the estrogen drop in perimenopause -       Why standard HRT dosing gets it wrong, and what blood levels to actually ask for -       Why TSH alone can't tell the full thyroid story, and what a full panel should include -       How chronic stress and trauma quietly drive long-term disease risk TIMESTAMPS 00:00 Why Cancer Rates Are Rising in Midlife Women 09:44 The Vitamin D, Omega-3 and Strength Training Protocol That Cut Cancer Risk by 60% 18:17 Perimenopause, Estrogen Exposure and Why HRT Dosing Alone Isn't the Answer to Cancer Risk 28:10 Hashimoto's, Thyroid Antibodies and Why TSH Alone Is Misleading You in Perimenopause 36:02 Inflammation, Cortisol and Chronic Stress: The Hidden Drivers of Disease Risk in Midlife 43:57 Trauma, Boundaries and Why Saying No Is a Non-Negotiable in Midlife Health 51:35 Full Body MRIs, Genetic Testing and Polygenic Risk Scores: What's Actually Worth Doing 59:03 Wearables, CGMs and the One Longevity Message Every High-Achieving Woman Needs to Hear .  VALUABLE RESOURCES ●      Synthesis Clinic (Dr. Nina's integrative oncology practice)

By the time the paper hit version 71, Dr. Nirosha Murugan had already done the hard part. The data were real. The experiment had worked. A team of researchers had used a wearable bioreactor to trigger limb regeneration in frogs, a result with obvious implications for regenerative medicine. But the science still wasn't getting over the line. The problem wasn't the work. It was the translation.On this episode of Standard Deviation, host Oliver Bogler talks with Dr. Nirosha Murugan, a biophysicist and Tier II Canada Research Chair in Tissue Biophysics at Wilfrid Laurier University, about what happens when a scientist working at the edges of quantum biology, bioelectricity, and tissue regeneration runs headfirst into the unwritten rules of academic publishing. Murugan's research asks biologists to think beyond molecules and chemistry alone, and to consider the physical signals, electromagnetic fields, and invisible forces that shape development and healing. It is ambitious science. It is also exactly the kind of work that can make gatekeepers nervous.Bogler follows Murugan through the less glamorous part of discovery: the hidden curriculum of getting a paper published, securing scientific credibility, and learning that data do not simply “speak for themselves.” Murugan describes how jargon buried the pitch of her own work, how a lack of editorial support left her at a disadvantage, and how the JEDI program at the Life Science Editors Foundation paired her with a former journal editor who taught her how to structure a manuscript, write a cover letter, and survive peer review.The result was publication in Science Advances, but the larger story is about power. Who gets taught the rules of biomedical research. Who has access to grant writers, editors, and institutional polish. Who is left to brute-force their way through the maze. And how one scientist, having finally found the map, now makes sure her own trainees do not have to learn it the hard way.RELATED LINKSDr. Nirosha Murugan⁠Wilfrid Laurier University⁠Life Science Editors Foundation⁠JEDI Program⁠Science Advances paper on limb regeneration⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Jess Peatross trained in conventional medicine and worked as a hospitalist before she started questioning why so many chronically ill patients kept getting worse inside the healthcare system she trusted. Her perspective carries weight because she spent years following every protocol exactly as taught before walking away from hospital medicine entirely.Raised in Huntington, West Virginia during the opioid crisis, she entered medicine believing the system existed to heal people. Instead, she found hospitals driven by billing codes, liability management, and pharmaceutical dependence while patients with chronic illness, autoimmune disease, mold exposure, and chronic pain cycled endlessly through appointments and prescriptions.Dr. Peatross explains what pushed her toward functional medicine, cannabis therapy, and prevention focused care after watching patients improve only after leaving conventional treatment pipelines behind. The conversation tackles physician burnout, chronic illness stigma, healthcare incentives, and the growing collapse of trust between patients and institutions.The discussion also moves into supplements, environmental toxins, ultra processed food, and the uncomfortable economics behind keeping people permanently sick but continuously billable. Dr. Peatross describes the professional backlash that comes with challenging medical orthodoxy while Matthew connects her experience to the broader erosion of public trust across American healthcare.Together they unpack what happens when patients stop believing the system can help them and start searching elsewhere for answers.RELATED LINKSDr. Jess PeatrossInstagramMarshall UniversityBrave New WeedFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Did you know that congenital CMV-related hearing loss can develop several years after birth? On the BackTable ENT & Allergy Podcast, hosts Dr. Gopi Shah and Dr. Jeff Hyzer interview pediatric otolaryngologist Dr. Albert Park about the latest evidence on congenital CMV and its role in pediatric sensorineural hearing loss. The discussion covers diagnosis, risk factors, screening protocols, testing strategies, antiviral treatment, genetic workup, long-term surveillance, and future directions for early detection and prevention. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction 02:47 - Basics of CMV Infections and Hearing Loss Presentation 07:57 - CMV Screening Workflow 11:33 - Saliva vs. Urine Based Screening 14:00 - Early Workup and Communication 19:37 - Late Onset Workup and Use of Antivirals 24:39 - Treatment with Antiviral Medications 27:22 - Head Ultrasound vs. MRI 30:06 - Role of Genetic Testing 32:47 - Surveillance and Progression Risk37:29 - CI Outcomes and Predictors42:18 - BAHA and Older Candidates45:44 - Awareness, Prevention Efforts, and Education 54:25 - Vaccines and Universal Screening Pitfalls 57:40 - Advocacy and Closing Thoughts --- More about this episode Dr. Park explains the differences between congenital and acquired CMV, reviews epidemiology and, and highlights that hearing loss may be present at birth or develop later in childhood. He discusses Utah's evolution from hearing-targeted CMV testing to universal NICU screening, emphasizing the importance of diagnosis within the first 21 days of life. The conversation covers saliva versus urine testing, dried blood spot testing, and the role of a multidisciplinary team in evaluation and management. Dr. Park also reviews antiviral treatment strategies, imaging and genetic testing considerations, audiologic surveillance, and cochlear implantation outcomes. Finally, he discusses ongoing advocacy efforts, emerging prenatal screening technologies, and future directions and challenges for CMV prevention and early detection. --- Resources Nance & Morton NEJM Paper Cited - 20% of Congenital SNHL linked to Congenital CMV https://www.nejm.org/doi/full/10.1056/NEJMra050700 Dr.Kimberlin's work supporting antiviral treatment for 6 months https://www.nejm.org/doi/full/10.1056/NEJMoa1404599?utm_source=openevidence Dr.Vossen's antiviral therapy research https://pubmed.ncbi.nlm.nih.gov/38336204/ AAP Red Book https://publications.aap.org/redbook Dr. Smith's Research - Genetic Testing for Congenital Bilateral Hearing Loss in the Context of Targeted Cytomegalovirus Screeninghttps://pubmed.ncbi.nlm.nih.gov/31985074/ Dr.Park's Research Congenital Cytomegalovirus Testing Outcomes From the ValEAR Trialhttps://pubmed.ncbi.nlm.nih.gov/38415855/ Dr.Park's Research - Analysis of an Expanded Targeted Early Cytomegalovirus Testing Programhttps://pubmed.ncbi.nlm.nih.gov/36884018/ Dr.Foulon - Hearing Loss With Congenital Cytomegalovirus Infectionhttps://pubmed.ncbi.nlm.nih.gov/31266824/ Research about the use of Vaclovir to reduce vertical transmissionhttps://pubmed.ncbi.nlm.nih.gov/32919517/ Dr.Gantt's research on the Ping-Pong Effecthttps://pubmed.ncbi.nlm.nih.gov/29889809/ --- BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Grief and healing often change the direction of our lives in ways we never expected. In this conversation, we explore child loss, healing through storytelling, resilience, and how one family transformed heartbreak into purpose and advocacy.I sit down with Dr. Matt Goldstein and Myra Sack to discuss the life and legacy of their daughter, Havi, who passed away from Tay-Sachs disease at the age of two. Together, they share how they navigated unimaginable grief, preserved their marriage, and found ways to honor Havi's impact on the world through storytelling, movement, community, and service.Myra shares insights from her book Fifty-Seven Fridays, while Matt discusses the inspiration behind JScreen, a nonprofit dedicated to expanding access to genetic testing and preventing hereditary diseases. Together, they offer a powerful perspective on grief, healing, public health, and the importance of living fully in the face of uncertainty.In this episode:• Honoring the life and legacy of Havi• Healing through storytelling and shared experiences• Preserving a marriage after the loss of a child• The role of movement, community, and ritual in grief• Turning pain into purpose and advocacy• Expanding access to genetic testing and healthcare• What families should know about preventive genetic screening• Finding meaning after profound lossConnect with Dr. Matt Goldstein and Myra Sack:JScreen: https://jscreen.orgE-Motion: https://emotion-mc.org

At just 32 years old, Keisha Kinison was working in women's health when she suddenly found herself as the patient. In this episode, we'll talk about what it was like to discover her diagnosis before a physician had the chance to call, why she made the difficult decision to change doctors during treatment, how her experience transformed her and the incredible support that helped carry her through. Woven throughout every chapter of her story is one powerful message: trust yourself, advocate for yourself, and never be afraid to seek the care you deserve. Key takeaways: Breast cancer can happen at a young age Self-advocacy is essential A strong support system makes a difference Treatment can involve unexpected setbacks Know your body and don't ignore changes Chapters 00:00 Keisha's breast cancer diagnosis at age 32 01:52 Testing, imaging, and receiving the diagnosis 05:12 Triple-negative breast cancer and treatment challenges 09:15 Advocating for herself and changing oncologists 12:11 The support that carried her through treatment 15:33 How cancer changed her career and advice for others Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

Amyloidosis: The Hidden Threat Of Aging After a 12-year NFL career, Art Still assumed his post-retirement medical issues were simply the natural price of football and aging. But he soon discovered that his failing health was due to a hidden, potentially fatal condition known as amyloidosis. Our experts explain the two main types of this disease, who's at risk, and the treatments that are available. Guests:  Art Still, former NFL player, founder, Still 4 Life Dr. Raymond Comenzo, professor of medicine, Tufts University School of Medicine   The Cost Of Care: The Alarming Rise Of Violence In Healthcare Hospitals are meant to be places of healing, but rising tension and uncertainty have turned them into environments of fear and conflict. Healthcare workers are now facing a terrifying surge of on-the-job physical assaults. Our experts explore the escalating severity of workplace violence and the prevention efforts being made. Guests:  John Voight, Vice President & Chief Nursing Officer, Memorial Hermann The Woodlands Medical Center Mike Shore, Senior Vice President & General Manager of Enterprise, Axon Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Amyloidosis: The Hidden Threat Of Aging After a 12-year NFL career, Art Still assumed his post-retirement medical issues were simply the natural price of football and aging. But he soon discovered that his failing health was due to a hidden, potentially fatal condition known as amyloidosis. Our experts explain the two main types of this disease, who's at risk, and the treatments that are available. Guest: Art Still, former NFL player, founder, Still 4 Life; Dr. Raymond Comenzo, professor of medicine, Tufts University School of Medicine Host and Producer: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Farla Efros is a senior retail executive and former CEO who built and sold companies before facing her own breast cancer diagnosis. She brings that same operational mindset into a healthcare system that expects patients to manage complexity while they are at their most vulnerable.She was on a client call in Spain when the diagnosis came through. A clear mammogram had missed it. An MRI caught it. Within hours, she was ordering binders, building a plan, and structuring her treatment like a turnaround strategy. Every appointment became a meeting. Every doctor faced an agenda with dozens of questions. She paid out of pocket for PET scans that were denied and hired a third party firm to validate her treatment path when her own doctors resisted outside input. The conversation tracks what happens when a high-functioning executive enters a system built on delay, denial, and fragmentation. Efros describes negotiating for tests, managing physician relationships, and assembling an “executive board” of advisors across conventional and alternative care. She calls the experience “the worst client I ever had,” exposing how administrative burden shifts onto patients and families.The tension sits between what worked for her and what is inaccessible to most. Her approach requires confidence, time, and fluency in navigating power. The system rewards that behavior while quietly failing patients who cannot replicate it. Insurance coverage still left her paying out of pocket. Doctors pushed standard protocols over precision medicine. Survivorship offered little support once treatment ended.This episode examines how cancer care operates as a series of incentives rather than a coordinated system, and why patients are forced to become operators just to get through it.RELATED LINKSFarla EfrosFarla Efros on LinkedInF*ck CancerF*ck Cancer on AmazonAccentureCTOAMPULL QUOTES“I treated cancer like the worst client I ever had.”“They wouldn't approve the test, so I paid for it myself.”“Every appointment was a negotiation.”FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In February, genetic technology gave investigators a new lead for a 1984 Fort Worth cold case: a woman found strangled at a landfill. In other news, a 15-year-old died Saturday after entering Lake Jacksonville in East Texas to help a young child whose inflatable device had drifted into deeper water; a man with a machete was allegedly shot and killed by his neighbor in Fort Worth Sunday; and two local coffee cafes are offering free drinks and coffee every Monday this summer. Capital One Café is offering free handcrafted beverages every Monday through Sept. 7. North Texas-based Pax & Beneficia Coffee is also offering free drinks every Monday at its Deep Ellum location.  According to Pax & Beneficia's Instagram page, everything, including drinks and food, are free all day to guests as a way to show gratitude to all of their supporters. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week on the goodsugar Podcast, Ralph Sutton sits down with Natalie Sampson, board-certified genetic counselor, integrative health expert, and founder of Golden Genetics Health, to separate science from hype when it comes to genetic testing.They dive into how your genes influence disease risk, supplements, medication response, inflammation, Alzheimer's, histamine intolerance, and even which workouts and nutrition strategies may work best for your body.Natalie also explains why most online DNA tests aren't telling you the full story, how personalized medicine is changing healthcare, and why genetics should empower, not scare, you.Whether you're curious about longevity, preventative health, or optimizing your wellness, this episode is packed with practical insights.00:00 Introduction00:41 Meet Genetic Counselor Natalie Sampson02:12 How Natalie Got Into Genetics03:54 Family Health & Autoimmune Disease Journey05:13 Nature vs. Nurture Explained08:23 What Genetic Tests Actually Show09:58 Chris Hemsworth & Alzheimer's Risk11:07 Can Saunas Reduce Alzheimer's Risk?12:00 Personalized Supplements vs. Trends13:21 Histamine Intolerance & Hidden Causes14:02 How Genetics Predict Medication Response15:15 Why Doctors Are Finally Embracing Genetics17:05 What Golden Genetics Health Does18:05 How Much Does Genetic Testing Cost?18:55 Blood Test vs. Saliva DNA Testing19:37 Why DNA Tests Are Different From Blood Work20:22 Is It Better NOT to Know Your Genetic Risks?21:43 Best Supplements for Most People22:45 Genetics Success Stories23:11 Biggest Misconceptions About Genetic Testing24:14 How to Avoid Bad Genetic Testing Companies25:10 Is 23andMe Accurate?25:54 Natalie's Celiac Disease Diagnosis27:09 Hidden Gluten & Surprising Triggers28:03 Why Some People Tolerate Gluten Better in Europe28:27 Where to Learn More About Golden Genetics Health29:03 Podcast Discount for Genetic Testing29:21 OutroFollow Natalie Sampson:

There is a lot of conversation right now about funding for cancer research and possible cuts to research projects that will improve our understanding and treatment of breast cancer. I'm pleased to be joined today by two researchers who are sharing their perspectives on the inextricable link between grant funding and sustained research. Dr. Benjamin Schrank is an Assistant Professor in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center, and Dr. Donald McDonnell is the Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology at Duke University School of Medicine. Dr. McDonnell is a well-established researcher whose work focuses on developing new drugs to treat metastatic breast cancer. Dr. Schrank is early in his research career and focused on harnessing the body's immune system to improve response to treatments for metastatic breast cancer. Both recently received research grants from Susan G. Komen to support their innovative work that will help improve breast cancer care and patient outcomes. Key Takeaways: Breakthrough cancer treatments can take decades to develop Fundamental research is the foundation of future therapies Early-stage funding is critical for innovation Research funding directly impacts patients Chapters 00:00 Introduction 01:40 Meet the researchers and their current projects 03:45 Why medical breakthroughs take decades to achieve 11:15 The critical role of grant funding in scientific research 20:20 Supporting the next generation of cancer researchers Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

Friday, June 26, 2026 - Week 26   BIO was good.  Need a mouse lab to test molecules all year long.   https://www.linkedin.com/posts/graglia_syngap-syngap1-mousemodels-ugcPost-7476041484408901633-Zldd/    MDBR was big, not just Justin A.!  Thank you Dr. McKee, Heather and others. cureSYNGAP1.org/MDBR26Recap    MERCH - 19 days left! New t-shirts!  Buy for everyone! There are some funny ones this year and the classics. cureSYNGAP1.org/Bonfire   GENETIC TESTING Valuable resource as you have questions. curesyngap1.org/GT     WARRIORS - Phoenix and Kenna cureSYNGAP1.org/Warrior    THINGS TO LOOK FORWARD TO…   WEBINAR: Understanding ASOs & Informed Consent June 30 4:30 ET curesyngap1.org/calendar/understanding-asos-informed-consent/    5TH SCRAMBLE FOR SYNGAP, SC – 99 days till October 3rd Classic case of a small event becoming an institution! cureSYNGAP1.org/Scramble26   SHOOT FOR SYNGAP, UT – 141 days till November 14th fb.watch/HRnwf9FnEB/   FIGHT FOR FELIPE, MA - 155 days till November 29th curesyngap1.org/Fight26    CURE SYNGAP1 CONFERENCE - 159 days until December 3rd & 4th cureSYNGAP1.org/Denver rooms available: ‭cureSYNGAP1.org/denhyatt for $159.  In on Wed, out on Saturday.   PUBMED Pubmed 2026 is at 38. +12 vs the week. (61 last year was +9) We are already at the 4th highest year. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date   Props to Dr. Frazier for yet another paper on SYNGAP1 based on his study, one of the best grants ever. https://onlinelibrary.wiley.com/doi/10.1111/dmcn.70337   USA

In this episode of DNA Dialogues, we explore two innovative approaches to improving access to genetic testing and hereditary cancer care. First, Daniella Kamara and Mariana Niell Swiller discuss UCLA's GENETECA™ program, a point-of-care genetic testing model that integrates cancer genetic services directly into oncology clinics. In the second half of the episode, Tesla Theoryn discusses research examining why many people who express interest in genetic testing never complete the process. The conversation explores how life circumstances, privacy and insurance concerns, changing readiness, and healthcare system barriers influence decision-making over time.   Segment 1: From the ground up: Launching GENETECA™ (GENetic education and TEsting for CAncer) a point-of-care cancer genetics service at an academic medical center   Guest Bios: Daniella Kamara, MS, LCGC is a cancer genetic counselor at University of California, Los Angeles (UCLA). She has been a cancer genetic counselor for over 10 years and works both in the clinical and research settings helping individuals and families who face a hereditary predisposition to cancer. She has contributed to various research studies over the years aiming to increase access to hereditary cancer testing, creating novel models for support for individuals and their family members, and exploring population-based testing models. She is passionate about supporting patients and their family members to feel empowered by their genetic test results and finding ways to make it easier to navigate healthcare for those facing a hereditary predisposition to cancer.    Mariana Niell-Swiller, MS, CGC, is a board-certified genetic counselor with 20 years of experience specializing in hereditary cancer risk assessment. She holds a BS in Biology from Cornell University and an MS in Genetic Counseling from Brandeis University, and began her clinical career after working as a molecular genetics laboratory technician in neurogenetics. She has since held clinical and leadership roles across a range of settings, from community hospitals to academic medical centers. In her current role as Director of Cancer Genetics at UCLA Health, Mariana leads both clinical program development and innovative IT infrastructure to expand access to hereditary cancer services. She is driven by the belief that thoughtfully designed systems can make genomic medicine more scalable, equitable, and sustainable — and is committed to advancing that vision across health systems. Outside of work, she enjoys kayaking, hiking, and dancing, and shares a love of nature with her husband and son. In this segment we discuss: - Increased access to genetic testing for pancreatic cancer patients through a point-of-care model - The benefits and challenges of mainstreaming genetic testing within routine oncology care - How genetic counseling assistants help improve efficiency, scalability, and patient access to cancer genetics services - Lessons learned from implementing GENETECA™ and balancing greater access with the personalized aspects of genetic counseling   Segment 2: Cancer genetic testing uptake in the primary care setting: Patient perspectives on barriers and facilitators throughout the testing process   Guest Bio: Tesla Theoryn, M.Ed., is a qualitative researcher and former high school science teacher with an applied interest in science communication and decision-making in the context of genetic testing. Her work focuses on how medical messaging and timing influence patient engagement and healthcare decisions. She is currently completing her doctorate from the University of Washington in Public Health Genetics. http://www.linkedin.com/in/theoryn   In this segment we discuss: - How life circumstances influence uptake of genetic testing - How re-offering genetic testing over time may change uptake as people's priorities, concerns, and readiness change - The impact of privacy, insurance, and legal concerns on genetic testing decisions - Strategies for expanding hereditary cancer screening in primary care while improving equity, accessibility, and patient-centered care Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   DNA Dialogues has been recognized as a Top 3 California Genetics Podcast and a Top 25 Molecular Biology Podcast by FeedSpot! Check out the recognitions here: https://podcast.feedspot.com/california_genetics_podcasts/ https://podcast.feedspot.com/molecular_biology_podcasts/   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.    DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Stephanie Schofield.

In 2020, Emily Mendenhall drove from Washington, DC to Okoboji, Iowa, a town of 800 that swells to 200,000 every summer, and walked into a pandemic that looked nothing like the one dominating national headlines. Inside gas stations and bars, masks marked you as an outsider. In one stop, a man told her family they would not be served if they kept theirs on. Her 6 year old daughter cried, confused. Mendenhall, a medical anthropologist at Georgetown University, did what she always does. She started asking questions. Over months, she interviewed neighbors, former classmates, and local officials, including her own brother in law who helped lead the local COVID response. The result became Unmasked, a case study in how community identity, economics, and politics shaped public health decisions in real time. That work led directly into her latest book, Invisible Illness: A History, from Hysteria to Long COVID, where she tracks a much older problem. Patients with chronic illness, especially women, often fail to meet medicine's demand for proof. Without a clear diagnosis, they lose access to care, insurance coverage, and legitimacy. Mendenhall argues that long COVID did not create this failure. It exposed it.This conversation centers on how healthcare systems reward certainty and punish complexity. Long COVID clinics send patients to 17 specialists without resolution. Insurance structures require diagnoses that many conditions cannot provide. Medical training still struggles to integrate trauma, mental health, and chronic disease into a coherent model of care.Mendenhall brings lived experience into the conversation. After COVID, she dealt with months of fatigue and escalating anxiety that altered her baseline health. She does not claim the label of long COVID, but she understands how quickly the system becomes harder to navigate once symptoms stop fitting clean categories. The stakes are not theoretical. In the United States, access to healthcare, disability benefits, and treatment still depends on whether a condition can be measured, coded, and reimbursed. For millions living with invisible illness, the burden of proof becomes the illness itself.RELATED LINKSEmily MendenhallInvisible Illness: A History, from Hysteria to Long COVIDScience PoliticsGeorgetown UniversityFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As Christians, we need to stay informed about the rapidly changing world of fertility treatments, genetic testing, and IVF before making decisions or forming opinions. Join C.L. as we explore the powerful story behind the Boozer family, wrestle with difficult questions about life, embryos, technology, and God's will, and seek biblical wisdom for navigating one of the most important ethical conversations of our time.

Welcome to the Komen Health Equity Revolution series on Real Pink — where patients, advocates, researchers and community partners come together to talk honestly about what's standing in the way of breast health equity, and what we're doing to change it. June is Pride Month — a time to celebrate identity, community and the courage it takes to live authentically. Today's conversation sits right at the heart of that. Because advocating for yourself, knowing your body and refusing to be dismissed, that's not just a health message. That's a love letter to who you are. Our guest today is Shelby Smith. She was 30 years old when she noticed something felt off. No family history of breast cancer. Young, healthy, going about her life as a wife and mom to a 7-year-old daughter. But she trusted herself — and that decision changed everything. Shelby faced a 12-centimeter tumor, a bilateral mastectomy, 16 rounds of chemo and 15 rounds of radiation. She did her own research, built her own notebook, asked her own questions — and came out the other side with a message she wants every young woman to hear: Know your normal. And when something doesn't feel right, advocate for yourself. Key Takeaways: Trust your instincts when something feels off Self-advocacy can change outcomes Being informed helps patients navigate treatment Cancer can affect more than physical health Including loved ones in the journey matters Chapters 00:00 Introduction: Shelby's Breast Cancer Story 02:07 Discovering a Lump and Seeking Answers 04:37 Diagnosis, Testing, and Receiving the News 10:07 Research, Self-Advocacy, and Navigating Treatment 17:33 Identity, Family, and Talking to Her Daughter 24:46 Life After Treatment and Advice for Young Women Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

At 25, Jace Yawnick was building a career in health and wellness sales, chasing growth, status, and the usual young adult fantasy of getting somewhere fast. Then his body stopped cooperating. Fatigue turned into chemotherapy. The diagnosis was primary mediastinal B cell non Hodgkin lymphoma, and the rest of his life split into before and after. Now in remission, he talks about cancer the way people actually live it, not the way nonprofits package it. He gets into survivorship, mental health, young adult isolation, and the deadening absurdity of prior authorization. One of the sharpest parts of the conversation lands on a simple American insult disguised as policy: treatment innovation means very little when insurance can still deny the scan, the drug, or the next step. Jace has seen that firsthand, including during routine monitoring after active treatment. This episode tracks what happens when a young cancer patient becomes a public voice and refuses to play mascot. It covers oncology, insurance, remission, advocacy, and the long mental hangover that follows survival. It also names the part too many institutions dodge: the system works great right up until it doesn't, and when it fails, patients get handed the bill, the panic, and a camera if they want anyone to care. RELATED LINKSJace Beats CancerJace Yawnick on LinkedImConquer Cancer ArticleCURE Today ArticlePyure BrandsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A breast cancer diagnosis may feel like it changes your entire life in an instant, but it doesn't get to define who you are or make all your choices for you. On today's episode of Real Pink, we're joined by Amanda Sangemino, a remarkable young woman whose diagnosis came at an age when cancer was likely the last thing on her mind. What began with a concern that was initially dismissed ultimately led her to trust her instincts, advocate for herself, and make a series of personal decisions about her treatment and future. Throughout the process, she was determined not to let fear and cancer make every decision for her. Today, she'll talk about the choices that she made about fertility, surgical options and maintaining an active lifestyle and why trusting yourself can be one of the most powerful tools you have. Key Takeaways: Mindset can play a powerful role during treatment Trust your instincts and advocate for yourself Maintaining normalcy can be empowering Don't let cancer make every decision for you A strong support system makes a difference Chapters: 00:00 – Amanda's Breast Cancer Story Begins 01:28 – Finding a Lump and Receiving a Misdiagnosis 04:22 – Seeking a Second Opinion and Getting Answers 07:00 – Why Self-Advocacy Matters for Young Women 10:00 – Fertility, Menopause, and Treatment Decisions 14:43 – Choosing Surgery, Staying Active, and Building Support 23:09 – Amanda's Final Advice Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

Drop us some Fan Mail. Thanks!Question: Our daughter is 11 months old and was adopted through an open adoption. We have a relationship with her birth mother, but don't yet feel it's the right moment to ask about family history, and her birth father is completely unknown to us. We do know that both birth parents are Hispanic, but beyond that, we have no additional information about her heritage or background. We want her to grow up with as rich a sense of her identity and heritage as possible. What guidance do adoption professionals offer around using genetic testing like 23andMe or AncestryDNA for adoptees? Is there an age-appropriate time to do this, or is it better to wait and let her decide for herself when she's older? Are there any other considerations unique to the adoptee experience we should keep in mind?Resources:Genetic Testing for Adoptees: Key Considerations and BenefitsGenetic Testing for Adoptees - Is It Worth It?Genetic Testing and Genealogy for AdopteesListen here to learn more about our Executive Director, Linda FioreSupport the showPlease leave us a rating or review.  This podcast is produced by www.CreatingaFamily.org. We are a national non-profit with the mission to strengthen and inspire adoptive, foster & kinship parents and the professionals who support them.Creating a Family brings you the following trauma-informed, expert-based content:Weekly podcastsWeekly articles/blog postsResource pages on all aspects of family building

At 20 years old, newly arrived from Puerto Rico and trying to build a future in science, Benjamin Suarez Jimenez found himself sitting in front of two senior faculty members accused of plagiarism. He knew the material. He had done the work. His mistake came from failing to cite class notes during an exam because nobody had told him that was expected. In a matter of minutes, he watched what felt like his entire career flash before him.On this episode of Standard Deviation, host Oliver Bogler examines the hidden architecture of academic science through the experiences of Dr. Benjamin Suarez Jimenez, Assistant Professor at the University of Rochester and a neuroscientist studying PTSD, anxiety, trauma, and spatial cognition through virtual reality and video game environments.Benjamin traces his path from Puerto Rico to the mainland United States, through the NIH, Columbia University, and eventually to leading his own laboratory. Along the way, he encountered a series of barriers that had little to do with scientific ability and everything to do with access to unwritten rules. From academic gatekeeping to grant writing expectations, he learned that success in biomedical research often depends on knowledge that never appears in a textbook.Oliver explores how those invisible obstacles shape careers, influence research funding, and determine who gains access to opportunity. The conversation also examines the Justice, Equity, Diversity, and Inclusion Program at the Life Science Editors Foundation, which pairs scientists from underrepresented backgrounds with experienced scientific editors. Through that mentorship, Benjamin transformed a critical grant proposal into a successful pilot award that helped launch an NIH R01 application.The discussion extends beyond one scientist's experience. Benjamin describes helping a former mentee navigate dissertation roadblocks that threatened her graduation, illustrating how institutional bureaucracy can delay careers and discourage talented researchers. Together, they explore the hidden administrative burden, cultural barriers, and bias that many scientists carry alongside their research, and what happens when someone who receives support turns around and opens the door for others.RELATED LINKSLife Science Editors FoundationBenjamin Suarez Jimenez LabDr. Benjamin Suarez JimenezBenjamin Suarez JimenezFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Sarah Matt trained as a burn surgeon, working in a field where patients arrive with catastrophic injuries and survival depends on speed, skill, and resources. She left the bedside after confronting a limit that medicine does not like to admit. One physician can only see so many people in a day. The system surrounding those patients decides the rest. She moved into health technology, held leadership roles in startups, and built global infrastructure at Oracle to scale care across populations. Then she watched billions of dollars in digital health and AI initiatives stall out when they hit real clinical environments.This episode follows that pivot from surgeon to strategist and back into direct patient care in rural New York, where she now treats uninsured patients, migrant workers, and communities pushed to the margins. The conversation centers on a persistent failure across healthcare systems. Products get built for regulators, executives, and investors instead of the people who use them. The result shows up in failed adoption, broken workflows, prior authorization delays, and rising physician burnout.The discussion cuts through health policy language and lands on lived consequence. The system rewards speed over usability, scale over trust, and compliance over care. Patients absorb the fallout. Physicians carry the liability. The incentives remain intact.RELATED LINKSDr. Sarah MattThe Borderless Healthcare RevolutionThe Clinical RealistJessica FedererSovatoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today on National Cancer Survivor's Day, we're joined by a remarkable performer whose strength, vulnerability, and resilience have inspired millions around the world. She has taken the stage as a backup vocalist for numerous top artists and most recently dazzled the crowds on the biggest tour in music history with global superstar Taylor Swift. However, audiences were moved even more deeply when she chose to publicly share something far more personal – her breast cancer journey. After Jeslyn Gorman's diagnosis become known through The Eras Tour docuseries, fans witnessed the emotional reality of navigating cancer while stepping away from a career and community she loves so deeply. From continuing to tour in the early days of diagnosis, to facing treatment side effects and returning to the stage immediately following treatment, her story is one of courage, grace and resilience. Today, Jeslyn opens up about the support she received, what survivorship looks like now and most importantly, shares an empowering message for young women about listening to their bodies, advocating for their health, and never underestimating the importance of early detection. Key Takeaways: Early detection can save lives. You can experience joy and fear at the same time. A strong support system makes a major difference. Recovery is gradual and requires patience. Cancer changes your life, but it doesn't define it. Chapters 00:00 – Jeslyn's Breast Cancer Diagnosis 05:24 – Continuing to Perform After Diagnosis 07:38 – Going Public With Her Cancer Story 13:22 – Breast Health and Self-Advocacy 18:07 – Support From Family, Friends, and the Tour Community 22:17 – Staying Positive During Treatment 25:17 – Chemotherapy and Physical Recovery 31:49 – Hair Loss and Identity Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship. 37:29 – Life After Treatment and Survivorship

How Young Lupus Patients Can Cope With Physical And Mental Health Issues Lupus is a chronic condition where a person's immune system attacks their healthy tissue. But while the physical toll is obvious, the extreme mental health issues that can arise are too often ignored. Our experts this week explain the connection between lupus and mental health, and discuss a program that's finally addressing these issues in young patients. Guests:  Natoshia Cunningham, Red Cedar Distinguished professor & associate professor in the Department of Family Medicine, Michigan State University, founder, TEACH Program Isabella Colindres, consumer advocate, TEACH Program Host and Producer: Kristen Farrah   Genetic Testing Is The Key To Optimizing Your Health Health optimization has become a huge focus in recent years, but many people are skipping the foundational step – genetic testing. Knowing the core of who you are helps direct you to the best medicine, diet, and exercise for you. Our expert explains the benefits of genetic testing and how to make sure you're getting quality results. Guest: Dr. Puya Yazdi, Chief Science & Medical Officer, SelfDecode Host: Greg Johnson Producer: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Genetic Testing Is The Key To Optimizing Your Health Health optimization has become a huge focus in recent years, but many people are skipping the foundational step – genetic testing. Knowing the core of who you are helps direct you to the best medicine, diet, and exercise for you. Our expert explains the benefits of genetic testing and how to make sure you're getting quality results. Guest: Dr. Puya Yazdi, Chief Science & Medical Officer, SelfDecode Host: Greg Johnson. Producer: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Linda Petticrew is one determined woman. She’s worked hard and many long hours to build a stunning career as an Executive Assistant to some of the top CEO’s in the city. But her real strength tenacity was when she faced breast cancer, not once but twice. Diagnosed at a young age, she fought and won her battle and then twenty years later had to fight it again. During this episode, Linda talks about her experience. And she gets candid about her treatment in the workplace and the difference an employer can make in the life of someone dealing with treatment. Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1.) How does maintaining a positive attitude and having a strong support system help in coping with a cancer diagnosis? 2.) Why are regular check-ups and screenings important for early detection and treatment of cancer? 3.) How can genetic testing provide valuable information for making informed decisions about preventive measures? 4.) What is the impact of cancer, beyond the individual and their entire family? Chapters 00:00 Introduction and Linda's Background 01:27 The Power of Executive Assistants and Supportive Work Environments 08:14 Maintaining a Positive Attitude and Overcoming Challenges 12:29 Genetic Testing and Preventive Measures 16:13 The Impact of Cancer on Family and Relationships 21:28 Prioritizing Family and Looking Towards the Future 23:17 Hope for a Cancer-Free FutureSee omnystudio.com/listener for privacy information.

In the late 1980s, a child exposed to fallout from the Chernobyl disaster lay in a hospital bed while doctors told his family there were no clear answers and no reliable path forward. Decades later, that same child, Yan Leyfman, walks into exam rooms as a hematology oncology fellow, expected to deliver clarity inside a system that still runs on delay, uncertainty, and institutional self preservation.This episode traces the throughline from early life shaped by radiation exposure and hospice level uncertainty to a career inside academic medicine, translational research, and oncology media. Yan built his identity around survival and usefulness, moving from patient to physician while carrying the memory of what it feels like to sit on the other side of the table. He helped launch MedNews Week during the COVID crisis to push back on misinformation and expand access to medical knowledge, stepping into a public role while still in training.The conversation stays grounded in the friction between personal narrative and system reality. Clinical training demands efficiency, hierarchy, and emotional distance. Cancer care demands time, clarity, and human connection. Those forces collide in real patient encounters where prior authorization delays, insurance barriers, and fragmented care pathways shape outcomes as much as any treatment protocol.Yan speaks openly about mentorship, belonging, and the drive to make meaning out of survival. The discussion pushes further into what the healthcare system actually rewards, what it quietly strips away, and how quickly empathy can erode under institutional pressure. The episode also examines the role of medical media, where education, industry influence, and narrative control often blur together.This is a conversation about identity under construction, about what happens when someone who remembers powerlessness steps into a role that carries authority, and about whether that memory can survive long enough to change anything.RELATED LINKSYan Leyfman on LinkedInYan Leyfman on InstagramSurviving ChernobylFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Debi Bryk has spent over eight years using functional genomics in clinical practice — and what she found changed everything about how she works with clients. In this conversation, Debi walks through the MaxGen Labs WORX panel, breaks down methylation in plain English, explains why MTHFR is only one piece of a much larger puzzle, and reveals why jumping straight to methylated B vitamins without knowing your COMT status can leave you feeling dramatically worse. She also unpacks how genetic variants in toxic response to plastics, pesticides, and seed oils can explain why some people develop chronic illness in environments that don't seem to affect others — and what you can actually do about it. Debi also explores the emerging role of lithium orotate in ADHD and Alzheimer's prevention, why low choline may be driving the mood and cognitive crisis more people experience every day, and shares her clinical framework for sequencing testing that dramatically accelerated healing and reduced costs for her clients by eliminating the guesswork entirely. Use code BEAUTIFULLYBROKEN for a discount on MaxGen Labs testing at MaxGen Labs.  Episode Highlights  [00:00] Understanding Genetic Variants and Their Impact [09:40] The Power of Genetic Testing [19:21] Methylation and Its Role in Health [29:04] Epigenetics: Environment and Gene Expression [32:17] Understanding B12 Levels and Genetic Implications [33:31] Genetic Risks: Alzheimer's and Toxins [36:33] Precision Medicine and Personal Health [38:21] Neurotransmitter Dynamics and Mental Health [38:52] The Role of MAO and COMT in Neurotransmitter Regulation [43:33] The Impact of Supplements on Mental Health [47:07] Nutritional Insights: Choline and Creatine [48:32] The Importance of Comprehensive Testing [50:09] Future of Peptide Research and Safety Concerns [54:17] Closing Thoughts on Health and Wellness   Upgrade Your Health MaxGen Labs: https://maxgenlabs.com/BEAUTIFULLYBROKEN   Code: BEAUTIFULLYBROKEN LightPathLED: https://lightpathled.pxf.io/c/3438432/2059835/25794 Code: beautifullybroken Silver Biotics Wound Healing Gel: https://bit.ly/3JnxyDD 30% off with Code: BEAUTIFULLYBROKEN StemRegen: https://www.stemregen.co/products/stemregen?_ef_transaction_id=&oid=1&affid=52 Code: beautifullybroken     . CONNECT WITH FREDDIEWork with Me: https://www.beautifullybroken.world/biological-blueprintWebsite and Store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/freddie.kimmelYouTube: https://www.youtube.com/@beautifullybrokenworld Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This episode originally aired in November 2023. When someone has metastatic breast cancer, it is scary for them - and for you! What can you do to really help? What should you say? Is it better to just listen? Today's guest received a de novo metastatic diagnosis in January 2021 and then elected to retire early from a 30-year technology sales career in order to slow life down and to focus on family, friends and thriving with MBC. Carlee Dixon's surprise diagnosis also inspired her to learn as much as possible about breast cancer and take every opportunity to educate friends and acquaintances about breast cancer prevention and the day to day reality. Today, Carlee is here to shed some light on how to best support those who are living with metastatic breast cancer.

Matthew Zachary is a brain cancer survivor, healthcare advocate, founder of Stupid Cancer and We the Patients, and host of Out of Patients. In April 2026, he returned to the stage at Merkin Hall near Lincoln Center for his first solo public piano concert in almost 22 years while launching his debut book, We the Patients: Understanding, Navigating, and Surviving America's Healthcare Nightmare.What unfolded became far larger than a concert.Over 2 hours, survivors, clinicians, advocates, nonprofit founders, journalists, pharmaceutical sponsors, and healthcare insiders gathered in one room to reflect on 30 years of survivorship, institutional failure, accidental advocacy, and the emotional afterlife of cancer. The evening moved through original piano performances, live chapter readings, and deeply personal conversations about infertility, disability, financial toxicity, insurance denials, grief, burnout, and what happens when patients spend decades navigating systems designed around transactions instead of continuity.Guests including Wendell Potter, Maimah Karmo, Craig Lustig, Shelly Fuld Nasso, Tamika Felder, and others reflected on how the modern cancer advocacy movement emerged largely because patients built parallel systems where healthcare infrastructure failed to meet human needs. The conversation explored how prior authorization, reimbursement incentives, administrative fragmentation, and institutional distrust continue shaping the patient experience across oncology and survivorship.The performance also marked a deeply personal milestone. After brain cancer compromised his left hand at age 21, Zachary spent 6 months rehabilitating both hands to return to public performance for the first time in over 2 decades. The result became part concert, part civic gathering, and part historical record of a generation of survivors who refused to disappear quietly.RELATED LINKSMZLIVE Official WebsiteMZLIVE YouTube VideoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Mitch and Amanda have recorded 208 Holy Health podcast episodes so far and this is the first official one where they talk pets! They share Lily's story and her Degenerative Myelopathy diagnosis as well as some other struggles Lily has had. They also talk about breeding, puppy mills, and why it's important to rescue. Finishing things off, they share about different types of food - kibble, cooked, or raw and what they feed Lily, and why. If you have furry friends, this is an episode you won't want to miss!DM Substack PostDr. Judy Morgan CookbookPodcast for more Lily talkConnect with us!YoutubeEmailInstagramMitch - SubstackMitch - InstagramMitch - FacebookAmanda - WebsiteAmanda - YoutubeAmanda - InstagramAmanda - Substackholyhealth222@gmail.comPlease share the show and leave a rating and review!

In December 1996, a 37 year old pharmaceutical executive sat in a Borders bookstore reading medical textbooks on the floor, trying to understand a disease she had never heard of. Multiple myeloma carried a three year prognosis. Her daughter was 18 months old. Her father had just died of cancer. Within weeks, she pushed her doctors to say the quiet part clearly. This would likely end her life before her child entered kindergarten.Kathy Giusti refused to accept passive survival. She built a plan while the system offered fragments. She interviewed oncologists and fertility specialists at the same time. She pursued IVF to have a second child while preparing for treatment. She stayed employed to keep insurance coverage. Every decision carried financial, medical, and emotional risk.That same urgency exposed a deeper failure. Cancer research moved slowly. Academic centers guarded data. Clinical trials lacked coordination. Patients entered a system that demanded compliance without providing clarity. Giusti responded by building the Multiple Myeloma Research Foundation, not as a support group, but as an operating engine to accelerate drug development, fund research, and force collaboration across institutions.This episode tracks the tension between individual agency and systemic failure. Giusti describes how patients navigate diagnosis, insurance barriers, and fragmented care in real time. She explains how data, genomics, and clinical trials reshape cancer treatment while still leaving patients responsible for decisions they are not trained to make. She addresses disparities in access, the limits of early detection, and the reality that progress in oncology often depends on speed, funding, and alignment of incentives.The conversation moves between lived experience and structural critique. It names the cost of delay, the burden placed on patients to act as their own advocate, and the tradeoffs required to push a system forward that still protects itself first.⸻RELATED LINKSKathy GiustiMultiple Myeloma Research FoundationFatal to FearlessAmerican Society of Hematology⸻FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's Women's Health Month — which means a lot of awareness messaging and a lot of conversation about why women's health matters. But today, we're going a level deeper. Because awareness doesn't save lives. Action does. Infrastructure does. Investment does. And honest conversations about why the system isn't working equally for everyone — those matter too. My guest today is Jenica Patterson — a neuroscientist turned health systems architect who is doing the hard work of figuring out why women's health is so chronically underinvested and what it will take to fix it. She leads the Women's Health Network at the Milken Institute, one of the most powerful cross-sector coalitions in this space. Before that, she built a $113 million federal program at ARPA-H (the Advanced Research Project Agency for Health) specifically designed to fast track innovation in women's health. Komen is focused on breast health access — and the sobering reality that where you live and what you look like still determine whether you get a timely mammogram, an accurate diagnosis or the best possible care. Jenica has the research, the relationships and the conviction to tell us exactly why that is — and what's possible. Key Takeaways: Women's health inequities are systemic, not individual. Nearly 30% of U.S. counties do not have a mammography machine. Women's health has historically been underrepresented in research and clinical development. Innovation alone is not enough without integration. Momentum in women's health is growing. Chapters 00:00 Jenica Patterson's journey from neuroscience to women's health systems leadership 05:45 Why women's health is at a major inflection point 08:40 The shocking mammography access gaps across the United States 14:02 Why solving women's health requires system-wide integration 20:03 Where momentum and hope are growing in women's health equity Learn more at realpink.komen.org and komen.org breastcancer #survivorship #womenshealth #cancersupport #realpink Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

  Genetic testing is no longer a distant, specialized tool reserved for rare disease clinics or academic centers. It's showing up in pediatric practice. For example, pediatricians are increasingly considering genetic diagnoses in children with developmental delays outside the normal range. A NICU graduate may already carry a genetic diagnosis when they see their pediatrician after discharge. What does the practicing pediatric provider need to understand about ordering and interpreting genetic tests?  In this episode, we unpack how community pediatricians can make sense of the world of genomics. Joining us for this robust conversation are Austin Larson, MD, and Margarita Saenz, MD. Dr. Larson is a pediatric medical and biochemical geneticist. He is the Medical Director of Precision Medicine Clinical Informatics, as well as the Director of the Mitochondrial Care Network Clinic at Children's Hospital Colorado. Dr. Saenz specializes in clinical genetics and dysmorphology. She is the Medical Director of Precision Medicine Education and Family Engagement. They both are faculty members at the University of Colorado School of Medicine. Some highlights from this episode include: Recent advances making genetic testing more accessible to patients  How the rise of exome and genome sequencing has changed the diagnostic approach in pediatrics  Secondary findings and how they should be discussed in advanced Practical advice for a pediatrician who feels overwhelmed to order and interpret these tests  For more information on Children's Colorado, visit: childrenscolorado.org. 

At 19, Shlomit woke up unable to speak. The right side of her body went numb. An emergency room sent her home and called it stress. That moment did not end in a diagnosis that changed policy or triggered reform. It sent her into a decade long pursuit of understanding how the brain fails language and how the healthcare system fails patients who cannot advocate for themselves.Shlomit trained as a speech language pathologist and spent years inside acute care hospitals and ICUs, performing endoscopies and treating patients with brain injury, stroke, and dysphagia. She watched medical teams rotate in and out, deliver dense updates, and leave families nodding without comprehension. She stayed behind and translated. Every day, patients told her she was the only one who explained what was happening. That gap is not an accident. Hospital systems optimize for throughput, not understanding. Patients move through beds based on cost, not readiness. Discharge planning becomes a financial decision wrapped in clinical language. A stay under 48 hours can shift the insurance burden dramatically, leaving patients exposed to higher out of pocket costs. Shlomit left the system and built Patient Path NYC, a private patient advocacy service. She now spends 15 to 20 hours a week per client reading charts, coordinating care teams, and translating medical decisions into plain language. Her work sits in the uncomfortable space between healthcare policy and lived experience. Families pay out of pocket to understand their own care. Hospitals benefit from the clarity she provides while maintaining the same structural incentives that created the confusion.This conversation tracks the human cost of fragmented care, the economics behind discharge decisions, and the quiet reality that patients who cannot communicate clearly often lose control of their own outcomes.RELATED LINKSShlomit LibertyShlomit Liberty on LinkedInPatient Path NYCBoard Certified Patient AdvocateFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter explores the complex and often misunderstood world of genetic testing, building a practical framework for understanding what these tests can and cannot actually tell us about health and disease. He explains why some genetic findings can be genuinely life-changing while many others offer information that is far more probabilistic than deterministic, and why directly measuring the phenotype is often more valuable than inferring risk from DNA alone. Peter examines where genetics can provide meaningful insight across the major disease categories and where its predictive power is far more limited than many people assume. He also discusses how to think critically about different types of genetic tests, how to interpret results in the proper context, and how to avoid the common trap of accumulating more genetic information without gaining greater clarity or actionable insight. We discuss: Genetic testing: understanding what it can reveal, where it falls short, and how to think about its clinical value [1:45]; The Human Genome Project: why decoding DNA did not immediately unlock the mysteries of disease [4:15]; The limitations of genetic testing: probabilistic risk, interpretive uncertainty, and the importance of phenotype [9:30]; Questions to ask when considering genetic testing [15:45]; Genetic testing in cardiovascular and metabolic disease: when genotype adds value beyond phenotype [17:00]; Genetic testing for inherited cardiac conditions: identifying hidden risk beyond routine screening [21:45]; Genetic testing for cancer risk: inherited syndromes, clinical utility, and the limits of consumer testing [24:00]; Genetic testing for neurodegenerative disease: risk prediction, planning, and the challenge of limited actionability [28:45]; Functional medicine genetic testing: the gap between biological plausibility and clinical evidence, and the supplement protocols that aren't supported by evidence [32:45]; Pharmacogenetics: using genetic testing to guide medication selection and safety [38:45]; A framework for evaluating genetic tests according to effect size and clinical actionability [41:45]; The major types of genetic tests, and how each should be matched to the clinical question being asked [43:30]; Interpreting genetic test results: choosing the right testing laboratory and understanding what the findings actually mean [49:45]; Framework summary: why genetic testing is most valuable when it is guided by a clear question, matched with the appropriate test, and capable of meaningfully influencing decisions [56:45]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Menopause – it may be the most unwanted time in a woman's life. It arrives with a vengeance, forcing all kinds of emotional, hormonal and bodily changes onto women as they approach their 50s. But for women going through breast cancer treatment, it can arrive even earlier and be even more unwanted. The good news is no one has to suffer in silence. Today's guests are Dr. Makeba Williams, the incoming president of The Menopause Society, and Claudia McConnell, a breast cancer survivor who was forced into menopause during breast cancer treatment at age 37. Key takeaways Breast cancer treatment can trigger sudden and emotionally overwhelming early menopause Menopause symptoms after cancer treatment are real, serious, and treatable. Mental health support is a critical part of breast cancer survivorship care. Open conversations help reduce stigma and empower women to seek support. Chapters 00:00 Introduction to breast cancer and menopause realities 04:29 Claudia's breast cancer diagnosis and sudden menopause at 37 15:42 Why survivors shouldn't suffer through menopause symptoms alone 19:20 New menopause treatments and advances for breast cancer survivors 21:07 Sleep disruption, insomnia, and menopause management strategies 24:07 Estrogen creams, vaginal health, and treatment decision-making 30:19 BRCA2, talking to children about cancer risk, and family support 39:05 Final advice for women navigating menopause after breast cancer Learn more at realpink.komen.org and komen.org breastcancer #menopause #survivorship #womenshealth #cancersupport #realpink Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

In 2020, developmental biologist Dr. Crystal Rogers drove the country roads outside Davis, California crying between grant rejections, wondering whether she was about to lose her lab, her career, and the scientific future she had spent years building. She had already done what academia tells young scientists to do. She earned the credentials. She landed a faculty position at UC Davis. She built a lab. Then the real test began.On this episode of Standard Deviation, Dr. Oliver Bogler examines the unspoken rules that determine which scientists survive academic research and which quietly disappear from it. The conversation follows Crystal Rogers and cancer biologist Dr. Michelle Mendoza as they collide with the “Hidden Curriculum” of biomedical science: the unwritten rhetoric, institutional signaling, and grant writing strategies that often decide who receives funding, tenure, and long term stability.Michelle Mendoza entered a tenure track position at the Huntsman Cancer Institute while raising 3 children, navigating a divorce, and trying to secure major NIH funding during COVID. What looked like objective scientific review turned out to depend heavily on persuasion, presentation, and insider fluency. Established researchers could promise massive research agendas based on reputation alone. Junior investigators faced a completely different standard.Oliver traces how the Life Science Editors Foundation and its JEDI program intervened by pairing scientists with former editors from journals including Cell and Nature. The work had little to do with commas or grammar. Editors challenged logic, structure, and scientific framing before grant reviewers could destroy an application in public.Both researchers eventually secured career defining grants. One realized she would keep her job and not have to move her family. The other celebrated by ordering a personalized “DEV BIO” license plate and driving through Davis blasting nineties hip hop and Beyoncé.The episode exposes how biomedical research funding rewards institutional fluency as much as scientific talent, and how hidden systems inside academic medicine continue shaping who gets to stay in science long enough to make discoveries.RELATED LINKSDr. Crystal Rogers LinkedInDr. Crystal Rogers Faculty PageDr. Crystal Rogers LabDr. Michelle Mendoza LinkedInDr. Michelle Mendoza Faculty PageHuntsman Cancer Institute Mendoza LabLife Science Editors FoundationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In 2008, Katy Talento walked away from Capitol Hill and into a Catholic convent. Within a year, she walked out. Within another decade, she sat inside the White House shaping health policy. Somewhere in between, she got labeled “infertile” after a single cycle of testing and spent years believing it.That label stuck. The pain that came before it never got investigated. Doctors offered birth control and moved on. No one asked why her body was struggling. No one followed the thread.Talento built her career inside the very systems she now critiques. She worked on federal health policy, global disease programs, and later advised the Trump administration on healthcare reform. She helped advance price transparency rules in a system where hospitals can still list 457 different prices for the same service.Then she left.Now she builds employer health plans that bypass insurers, PBMs, and traditional networks. Her approach replaces insurance contracts with direct payment, nurse navigators, and cost sharing models that promise simplicity but raise hard questions about risk and protection.This conversation sits in that tension.Talento describes a healthcare system shaped by layered incentives, where insurers, hospitals, and intermediaries profit from complexity. She argues that employers hold the leverage to disrupt it. The host pushes on what happens when patients fall outside those structures, when contracts disappear, and when community based models fail.The episode moves through infertility, misdiagnosis, insurance design, and the mechanics of employer sponsored care. It tracks how policy decisions made in Washington ripple into exam rooms, billing departments, and family lives.It also confronts a harder truth.Even insiders who understand the system can still get caught in it.RELATED LINKSAllBetter HealthKaty TalentoThem Before UsAn Arm and a LegRelentless Health ValueFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

While menopause is often associated with aging, many women facing breast cancer experience it suddenly and much earlier than expected—bringing a wave of physical and emotional changes. From managing intense symptoms to confronting fears about future family-building, the journey can feel overwhelming. On today's episode, we are joined by Melody Johnson, a nurse practitioner who specializes in caring for women navigating these exact challenges. She will help us understand how treatment-induced menopause differs from natural menopause and the strategies available to cope with side effects while already carrying so much. We'll also take a closer look at fertility—an especially emotional and complex issue for younger women diagnosed before they've had the chance to start or grow their families. Whether you're newly diagnosed, supporting someone who is, or simply want to better understand this critical aspect of women's health, this conversation is here to inform, support, and remind you: you are not alone on this journey. What You'll Learn: • The difference between treatment-induced and age-related menopause • Common symptoms and why they can feel more severe during cancer treatment • How to manage menopause side effects alongside a breast cancer diagnosis • Fertility preservation options, including egg freezing and when to consider them • Why self-advocacy is critical when discussing fertility with your care team Chapters: 00:00 Introduction to treatment-induced menopause 01:29 Melody Johnson's background in oncofertility 02:45 What to expect from menopause symptoms 05:05 Key differences between induced and natural menopause 06:24 Managing symptoms during treatment 08:29 Fertility concerns for younger women 10:25 Is treatment-induced menopause permanent? 11:53 Questions to ask your doctor 13:24 Why these conversations matter 14:48 Final advice for women navigating fertility after diagnosis Learn more at komen.org and realpink.komen.org BreastCancer #Fertility #Menopause #WomensHealth #Oncofertility #CancerSupport #ReproductiveHealth #RealPink Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

In a wooded campground cabin in the early 2000s, 19 year old Ben Unger stood in the doorway and watched 20 naked men form a circle around a crying teenager. A counselor held up two tangerines and shouted, “These are your balls.” The exercise claimed to cure same sex attraction by forcing young men to “reclaim” their masculinity from overbearing mothers. Phones had been confiscated. Parents had paid thousands of dollars. Religion supplied the script. Pseudoscience supplied the props.Ben had grown up in an Orthodox Jewish community in Brooklyn and later studied in Israel to become a rabbi. When he admitted he felt attracted to men, rabbis told him to eat 7 figs a day, immerse in a ritual bath 5 times daily, or marry a woman and trust that “if there's friction, it works.” At 19, he entered conversion therapy through an organization called Jews Offering New Alternatives to Homosexuality, known as JONAH. He left with depression, religious trauma, and 6 months of silence toward the mother he had been taught to blame.Years later, represented by the Southern Poverty Law Center, Ben helped sue JONAH for consumer fraud in a landmark New Jersey case. The argument centered on evidence, not theology. Sexual orientation cannot be changed. The jury deliberated for 3 hours and ruled against the organization. The verdict helped reshape how states regulate conversion therapy and protect minors from psychological harm disguised as treatment.Today, Ben runs Buff Personal Training in New York City, a gym built on autonomy, mental health, and self respect. His story traces the arc from institutional control to self authorship. The conversation examines religion, LGBTQ rights, conversion therapy, consumer protection law, and the lasting cost of being told your identity is a disorder.RELATED LINKSBen Unger on LinkedInBen Unger on InstagramBUF Personal TrainingSouthern Poverty Law CenterJONAHFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today's conversation is one that so many mothers will feel deep in their bones because it talks about what happens when life asks you to be the one who needs care. Our guest today has lived that shift in a profound way. In the midst of raising her young children, navigating the everyday chaos and fiercely advocating for her youngest daughter, Nylah, who was born with congenital heart disease, Nisha Jaime was suddenly diagnosed with breast cancer. There is an emotional whiplash to being the strong one for your child and then suddenly needing that same strength for yourself. Nisha will talk to us about what that was like and how she balanced it all with the help of her village. We'll talk about the ongoing realities of survivorship, including things like scanxiety and continued care and how her children are involved in her journey. Most importantly, we'll hear how she has turned her experience into support for other mothers walking a similar path and why that mission matters so deeply to her.

Europe's borders in the Middle Ages were created by one man, and he wasn't even born in the Middle Ages, nor was he Christian. It was Emperor Diocletian, who ruled Rome from 284 to 305. His reforms that chained tenant farmers to land created the blueprint for feudalism. He split the empire, which established the East-West divide. Lastly, his shift from static Roman legions to mobile armies set the stage for the warrior kingdoms that would dominate the early Middle Ages. Today, new genetic analysis of skeletal and tooth remains is revolutionizing how we understand this transformation—a high-status woman buried around 550 in Britain was born in Norway according to her childhood tooth enamel, proving the "barbarian invasions" were actually century-long migrations averaging just three miles per day. Today's guest is John Haywood, author of The Making of the Middle Ages: An Atlas of Europe. We discuss how Europe from 500-700 was ruled by warrior kingdoms with mobile courts that constantly traveled—only shifting to fixed courts and proper imperial administration after Charlemagne established counties, libraries, copyists, and the emporia trading centers where workshops and markets flourished. Haywood also explains how Ravenna's independence from Byzantium portended the rise of papal power, why towns collapsed from Roman populations of thousands to mere hundreds unless a bishop resided there, and how the density of churches and monasteries north of the Alps exploded between 600 and 1200 as the Catholic Church consolidated power across formerly pagan Germanic territories.See omnystudio.com/listener for privacy information.

Dr. Natalie Crawford, MD, is a double board-certified OB-GYN and reproductive endocrinologist. We discuss how to improve hormone health at any age and the importance of fertility markers not just for pregnancy, but as a powerful window into overall health, vitality and longevity. We discuss hormone replacement therapy, egg freezing, IVF, and what biomarkers like AMH really indicate. Plus, how anti-inflammatory diets and specific supplements can be beneficial and the impact of microplastics and certain fragrances on hormones. We also discuss lesser-known factors that deplete male and female fertility, vitality and health. This conversation highlights how better understanding of hormones and your reproductive markers can empower better informed choices at every stage of life. Read the show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman David: https://davidprotein.com/huberman BetterHelp: https://betterhelp.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Natalie Crawford (00:02:26) Fertility as a Health Marker, Infertility (00:05:34) Perimenopause, Menopause, Hormone Replacement Theory (00:11:01) Sponsors: David & BetterHelp (00:13:35) Hormone Therapy, Extending Ovarian Lifespan (00:19:11) Plastics, Toxins & Fertility (00:22:02) Does Prior Pregnancy Make Conception Easier?, Secondary Infertility (00:29:02) Testing Sperm; Pregnancy Loss & Conceiving Again, Fertility Testing (00:38:17) Sponsor: AG1 (00:39:40) Menstrual Cycle, Egg Number & Quality, AMH Test (00:48:17) Tool: AMH Test; Fertility Education & Patient Choices (00:53:13) Tool: Tracking Ovulation; Ovulation Disorders (00:55:11) AMH Test Cost; Genetic Testing & Patient Choice (01:01:13) Does Egg Freezing Cause Early Menopause?, In Vitro Fertilization (IVF) (01:05:29) Egg Freezing, IVF, Ethical Concerns; Embryo Banking (01:15:21) Sponsor: Eight Sleep (01:16:39) Egg Freezing, Cost & Patient Choices (01:21:22) Concieving After Hormonal Birth Control, IUD or Depo-Provera (01:27:17) Pregnancy Termination & Concieving Again (01:29:28) Support Egg Quality, Tools: Ovulation & Avoiding NSAIDs; 5 Lifestyle Non-Negotiables (01:34:03) Sleep, Melatonin; Cold Plunge (01:38:41) Curcumin, NAD/NR, CoQ10, Supplements for Prenatal Care & Sperm Health (01:42:05) Sponsor: Function (01:43:16) Fertility Research into Supplements & Lifestyle Factors (01:48:21) Inflammation, Red Light (01:53:12) Cannabis & Detriments to Egg & Sperm Health (01:58:57) Nicotine, Smoking, Egg Health & Sperm Count; Healthy Lifestyle Practices (02:02:21) GLP-1s, PCOS, Endometriosis; Human Growth Hormone (02:10:58) Platelet-Rich Plasma; Paternal Age & Sperm Quality; Biotin (02:17:27) Endocrine Disruptors, Fragrances, Receipts, Tool: Fragrance-Free (02:22:48) Patient Education & Empowerment; Inflammation, Celiac Disease (02:25:40) Anti-Inflammatory Diet, Protein, Fiber, Red Meat (02:33:25) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices